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Background:  Epidemiological  data  on  cutaneous  wart-associated  HPV  types  are  rare.
Objectives:  To  examine  the prevalence  of cutaneous  wart-associated  HPV  types  and  their  relation  with
patient  characteristics.
Study design:  Swabs  were  taken  from  all 744  warts  of  246  consecutive  immunocompetent  participants
and  analysed  by  a broad  spectrum  HSL-PCR/MPG  assay.  Patient  details  including  location,  duration,  and
number of  warts  were  recorded.
Results:  No  HPV  DNA  was  detected  in  49  (7%)  swabs,  a  single  HPV  type  in 577  (78%) swabs,  and  multi-
ple  HPV  types  in 118  (16%)  swabs.  HPV  2, 27  and  57  (alpha  genus),  HPV  4 (gamma  genus)  and  HPV  1
(mu  genus)  were  the  most  frequently  detected  HPV  types,  and  HPV  63  (mu  genus)  was  only  frequentlyatient characteristics detected  together  with  other  HPV  types.  Less  frequently  detected  HPV  types  were  HPV  3, 7,  10  and  28
(alpha  genus),  65, 88  and  95  (gamma  genus)  and  41  (nu genus).  Warts  containing  HPV  1  showed  the most
distinct  clinical  proﬁle,  being  related  to  children  aged  <12  years,  plantar  location,  duration  <6  months,
and  to  patients  with  <4  warts.
Conclusions:  HPV  27,  57,  2  and  1 are  the  most  prevalent  HPV  types  in  cutaneous  warts  in general  popu-
h  HPlation.  Warts  infected  wit
. Background
Cutaneous warts are benign papillomas of the skin of which
ommon warts (verrucae vulgaris) and plantar warts (verrucae
lantaris) are the most common types. Up to one third of primary
chool children have cutaneous warts.1 Although cutaneous warts
ave a benign natural history, they cause signiﬁcant physical and
sychological inconvenience. Therefore, patients with warts fre-
uently consult physicians, mostly in primary care.2,3
Warts are caused by infection with human papillomavirus
HPV). More than 120 HPV types, distributed over 5 genera and 16
pecies, have been described based on their DNA sequences.4,5 HPV
, 7, 27 and 57 from the alpha genus, HPV 4 and 65 from the gamma
Abbreviations: HPV, human papillomavirus; HSL, hyperkeratotic skin lesion;
CR/MPG, polymerase chain reaction/multiplex genotyping; CI, conﬁdence interval.
∗ Corresponding author at: Leiden University Medical Center, Department of Pub-
ic  Health and Primary Care, PO Box 9600, 2300 RC Leiden, The Netherlands.
el.: +31 71 5268444; fax: +31 71 5268259.
E-mail address: s.c.bruggink@lumc.nl (S.C. Bruggink).
386-6532     © 2012 Elsevier B.V.  
ttp://dx.doi.org/10.1016/j.jcv.2012.07.014
Open access under the Elsevier OA license.V  1  have a  distinct  clinical  proﬁle.
© 2012 Elsevier B.V.
genus, and HPV 1 from the mu genus have most frequently been
detected in cutaneous warts.6–11 However, epidemiological data on
cutaneous wart-associated HPV types are rare, and available stud-
ies are conducted in selected patient groups such as patients from
dermatology clinics. The prevalence of cutaneous wart-associated
HPV types in the general population is largely unknown.
Speciﬁc types of infecting HPV are correlated with histological
characteristics and, to a lesser extent, with morphological features
of warts.12–16 Clinical characteristics other than morphological
wart features may  be useful to predict the prognosis and make
treatment decisions. For example, the decisions of patients to con-
sult physicians, and of physicians to start treatment, are inﬂuenced
by the age of the patients as well as the location, duration, and num-
ber of warts.3,17,18 Little is known about the relation between these
patient characteristics and associated HPV genotypes.
Open access under the Elsevier OA license.2. Objectives
This study examines the prevalence of wart-associated HPV
types in a large sample of patients with cutaneous warts in
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Table 1
Patient characteristics of the study population (n = 246).
Sex
Female 150 (58.9)
Male 96 (41.1)
Age
4–11  years 107 (43.5)
12–20 years 45 (18.3)
21+ years 94 (38.2)
Location of warts
Plantar warts only 103 (41.9)
Common warts only 108 (43.9)
Plantar as well as common warts 35 (14.2)
Duration of oldest wart
<6 months 100 (40.7)
≥6  months 146 (59.3)
Number of warts
1 91 (37.0)
2 47 (19.1)
3  33 (13.4)
4 24 (9.8)
5  13 (5.3)
6  or more 38 (15.4)
Presence of wart cluster 60 (24.4)
Warts cause inconveniencea 184 (74.8)S.C. Bruggink et al. / Journal of 
rimary care, and explores the relation between HPV types and
atient characteristics.
. Study design
.1. Patients and samples
We collected our samples from the warts of the participants of
he Warts Randomised Treatment Study (WARTS).17 All patients
ged ≥4 years who attended one of the 50 participating family
ractices with one or more new cutaneous warts were invited to
articipate in this trial. We  deﬁned new warts as warts on the
kin that were presented for the ﬁrst time without prior treat-
ent from a family physician or dermatologist in the previous year.
e excluded immune compromised patients, patients with genital
arts, seborrheic warts, or mosaic warts ≥1 cm in diameter. Trained
esearch nurses conﬁrmed eligibility and obtained informed con-
ent. Details on patient inclusion are already published.17
The protocol was approved by the medical ethical committee
f the Leiden University Medical Center. The research nurses took
wabs from each single wart by ﬁrmly rubbing a pre-wetted cotton-
ipped stick over the surface of the wart ﬁve times. This swab
echnique adequately detects HPV types present in wart scab as
ell as wart biopsy.19 Only when warts were too close to take sep-
rate swabs, was a single swab taken from the cluster of warts. We
onsidered multiple warts as a cluster when the distance between
arts was ≤1 cm.  All swabs were stored in 1 ml of saline solution.
.2. HPV identiﬁcation
We used a newly developed broad spectrum PCR/MPG assay for
enotyping all known wart-associated HPV types from the alpha-
HPV 2, 3, 7, 10, 27, 28, 29, 40, 43, 57, 77, 91 and 94), gamma- (4,
5, 95, 48, 50, 60 and 88), mu-  (HPV 1 and 63) and nu-genus (HPV
1) to determine HPV distribution. This sensitive and speciﬁc assay
HSL-PCR/MPG assay; Labo Bio-medical Products B.V., Rijswijk, The
etherlands) has been described and evaluated by de Koning et al.20
n short, 10 l of the saline solution was used in the single-step
SL-PCR, generating a biotinylated amplimer of 76–84 bp from the
1 region. Subsequently, simultaneous identiﬁcation of the 23 HPV
enotypes was performed with bead-based xMAP suspension array
echnology. Negative samples were not analysed any further. All
CRs were carried out with all precautions to avoid contamination
escribed by the manufacturer. Negative PCR and genotyping con-
rols were incorporated and remained negative upon analysis with
he HSL-PCR/MPG assay.
.3. Patient characteristics
We recorded the following characteristics: sex (male vs.
emale); age (4–11 years vs. 12–20 years vs. 21 years and older);
ocation of warts (plantar warts [warts on the soles of the feet]
s. common warts [warts on other locations than soles of the feet,
ostly hand warts]); duration of warts at the time of investiga-
ion (≤6 months vs. >6 months); number of warts per patient (<4
s. ≥4 warts); part of cluster of warts (yes vs. no); inconvenience
aused by warts (pain, irritation, or cosmetic inconvenience; yes
s. no). For statistical purposes and clear presentation of results,
he characteristics were dichotomized with cut-off values closest
o the median.
.4. Statistical analysisPrevalence with 95% conﬁdence interval (CI) was calculated for
arts associated with a single HPV type and for warts associated
ith multiple HPV types. We  used warts with a single HPV typeData are numbers of patients (%).
a Pain, irritation, or cosmetic inconvenience.
in our primary analysis. All HPV types were stratiﬁed according
to dichotomized patient characteristics. We considered a number
of <30 warts per HPV type too small to reliably investigate their
relation with patient characteristics. For the most prevalent HPV
types, proportions of warts per characteristic were compared using
95% CI.
In the sensitivity analyses, prevalence and clinical proﬁles
were calculated with a proportional weighting attribution, which
includes information about warts with multiple types.21–23 For
example, in a wart with multiple types consisting of HPV 2 and
HPV 4 where prevalence in single types is 22% and 5%, respectively,
using the proportional attribution, the case would be split between
the two types with the prevalence in single types used as reference:
22/27 for HPV 2 and 5/27 for HPV 4.
To explore the different types involved in warts with multi-
ple HPV types, we  compared observed numbers of speciﬁc 2-type
combinations with expected numbers, which were obtained by
multiplying the prevalence of both HPV types in warts with a sin-
gle type, multiplied by the total number of warts. We also repeated
analyses of prevalence and clinical proﬁles with patients instead of
warts as unit of analysis, and assessed concordance of HPV types
within patients with multiple warts calculating the proportions of
patients sharing one HPV type in all warts.
4. Results
4.1. Patients and samples
Of the 250 included patients, 246 provided wart swabs for HPV
testing. The swabs of 4 patients were lost in transport to the lab-
oratory. Median age was  13 (range 4–73) years and 59% of the
participants were female (Table 1). At study entry, 91 patients (37%)
had one wart, 117 (58%) had 2–5 warts, and 38 (15%) had 6 or more
warts. Sixty patients (24%) had at least one cluster of warts. Fur-
thermore, 103 patients (42%) had plantar warts only, 108 (44%) had
common warts only, and 35 (14%) had both plantar and common
warts. All 744 warts from these 246 patients were analysed: 373
plantar warts (50%) located on the soles of the feet, and 371 com-
mon  warts (50%) of which 75% was located on hands and 25% on
the rest of the body.
2 Clinical Virology 55 (2012) 250– 255
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.2. HPV type prevalence
From the 744 swabs, 49 (7%) were negative for HPV DNA, 577
78%) were positive for a single HPV genotype, and 118 (16%) swabs
ontained DNA of multiple HPV types. In total, 217 warts (29%)
ere part of a cluster, of which 27 clusters providing 69 warts had
een swabbed with a single swab because warts were too close to
ake separate swabs. In these swabs, the proportion of swabs with
ultiple HPV types was equal to the proportion in all swabs (also
6%).
Table 2 presents the prevalence of HPV types in all HPV-positive
arts. Most prevalent HPV types in warts with a single HPV type
ere HPV 27 (24%), HPV 57 (22%), HPV 2 (22%), and HPV 1 (19%).
heir combined relative contribution was 86% (95% conﬁdence
nterval (CI) 83–88%). Furthermore, HPV 4, HPV 65, HPV 28, HPV
 and HPV 10 were each present in 1–5% of swabs, and HPV 7, HPV
3, HPV 41 and HPV 95 in <1%. The prevalence of HPV types in all
arts according to the proportional attribution was comparable to
he prevalence in warts with a single HPV type (Table 2).
.3. HPV type and patient characteristics
Table 3 presents data on the relation between patient character-
stics and the detected HPV types in warts associated with a single
PV type. The four most prevalent HPV types were related to spe-
iﬁc clinical proﬁles (Fig. 1). Warts with HPV 1 showed the most
istinct clinical proﬁle, being related to children aged <12 years,
lantar location, duration <6 months at the time of investigation,
nd to patients with <4 warts. For these characteristics, the 95%
I for HPV 1 did not overlap the 95% CI of all warts, nor the CI of
he other most prevalent HPV types. Warts with HPV 27 and warts
ith HPV 57 had a similar clinical proﬁle which slightly differed
rom warts with HPV 2: HPV 27/57 were related to patients aged
12 years, especially to patients aged 21+; HPV 2 was  related to
ocation on the hands (Table 3). Less frequently detected HPV types
ere found in warts with short as well as long duration.
.4. Warts with multiple HPV types
In warts associated with multiple HPV types (n = 118), HPV 4 and
PV 63 were also involved in >20% in addition to the highly preva-
ent HPV 27, 57, 2 and 1 (Table 2). Warts with double HPV types
n = 94) were observed less frequently than expected (Table S1). The
ombination of HPV 2 and 4 (n = 18), and the combination of HPV 1
nd 27 (n = 18) were the most prevalent. In all observed combina-
ions, one of the four most prevalent HPV types was  present, with
he exception of the combination HPV 65 and 28 (n = 1). Remark-
bly, the combination of HPV 1 and 57, and the combination of
PV 1 and 2 were not observed, while combinations with HPV 63
n = 10) were more prevalent than expected. Patient characteris-
ics of warts with combinations of multiple types did not reveal
igniﬁcant proﬁles (data not shown).
.5. Patients with multiple warts
When patients were used as unit of analysis, HPV prevalence
Table S2)  and clinical proﬁles (data not shown) were in line with
he results in warts. In 74% of patients with multiple warts (n = 150),
ll warts shared one HPV type. In a further 23% of patients with
ultiple warts some but not all warts shared one HPV type. As an
xample for this, a 6 year old boy had a plantar wart associated
ith HPV 65 and two hand warts, of which one was  also associ-
ted with HPV 65 but the other with HPV 57. Within all clusters of
arts (n = 82), the HPV positive warts shared one HPV type, with the
xception of one plantar cluster of 3 warts, where in one wart HPV
7 was detected and in the other two warts HPV 57 was detected. Ta
b
le
 
2
H
u
m
an
 
p
ap
il
H
PV
 
ty
p
ea
27
 
57
 2 1 4  65
 
28
 3 10 7
 
63
 
41
 
95
 
88
 
H
PV
 
ty
p
es
 
29
a
O
n
e 
of
 
th
b
Th
e 
m
ea
n
c
R
ou
n
d
ed
d
Su
m
 
of
 
p
S.C. Bruggink et al. / Journal of Clinica
Ta
b
le
 
3
C
li
n
ic
al
 
p
ro
ﬁ
le
s 
of
 
al
l i
d
en
ti
ﬁ
ed
 
H
PV
 
ty
p
es
 
in
 
w
ar
ts
 
w
it
h
 
si
n
gl
e 
H
PV
 
ty
p
e 
(n
 
= 
57
7)
.
Pa
ti
en
t 
ch
ar
ac
te
ri
st
ic
 
A
lp
h
a 
G
am
m
a 
M
u
 
N
u
 
A
ll
 
w
ar
ts
n 
=  
57
7
Sp
ec
ie
s 
2 
Sp
ec
ie
s 
4 
Sp
ec
ie
s 
8 
Sp
ec
ie
s 
1 
Sp
ec
ie
s 
1 
Sp
ec
ie
s 
2 
Sp
ec
ie
s 
1
H
PV
 
3
n 
= 
10
H
PV
 
10
n 
= 
8
H
PV
 
28
n 
= 
13
H
PV
 
2
n 
= 
12
5
H
PV
 
27
n 
= 
13
7
H
PV
 
57
n 
= 
12
6
H
PV
 
7
n 
= 
3
H
PV
 
4
n 
= 
29
H
PV
 
65
n 
= 
14
H
PV
 
95
n 
= 
1
H
PV
 
1
n 
= 
10
7
H
PV
 
63
n 
= 
2
H
PV
 
41
n 
= 
2
M
al
e
3
(3
0)
 
0
(0
)  
4
(3
1)
 
46
 
(3
7)
 
39
 
(2
8)
 
32
 
(2
5)
 
3 
(1
00
) 
19
 
(6
6)
 
7 
(5
0)
 
1 
(1
00
) 
49
 
(4
6)
 
0 
(0
) 
0 
(0
) 
20
3 
(3
5)
A
ge 4
–1
1 
ye
ar
s 
3 
(3
0)
 
0 
(0
) 
4 
(3
1)
 
54
 
(4
3)
 
36
 
(2
6)
 
28
 
(2
2)
 
0 
(0
) 
19
 
(6
6)
 
10
 
(7
1)
 
0 
(0
) 
89
 
(8
3)
 
0 
(0
) 
0 
(0
) 
24
3 
(4
2)
12
–2
0  
ye
ar
s  
0
(0
)  
0
(0
)  
0
(0
)  
51
(4
1)
 
44
(3
2)
 
38
(3
0)
 
0
(0
)  
1
(3
)  
1
(7
)  
0  
(0
) 
8 
(7
) 
2 
(1
00
) 
0 
(0
) 
14
5 
(2
5)
21
+ 
ye
ar
s
7 
(7
0)
 
8 
(1
00
) 
9 
(6
9)
 
20
 
(1
6)
 
57
 
(4
2)
 
60
 
(4
8)
 
3 
(1
00
) 
9 
(3
1)
 
3 
(2
1)
 
1 
(1
00
) 
10
 
(9
) 
0 
(0
) 
2 
(1
00
) 
18
9 
(3
3)
Pl
an
ta
r  
lo
ca
ti
on
0
(0
)  
0
(0
)  
0
(0
)  
39
(3
1)
 
72
(5
3)
 
70
 
(5
6)
 
0 
(0
) 
18
 
(6
2)
 
10
 
(7
1)
 
0 
(0
) 
86
 
(8
0)
 
2 
(1
00
) 
2 
(1
00
) 
29
9 
(5
2)
<6
 
m
on
th
s 
d
u
ra
ti
on
 
0 
(0
) 
0 
(0
) 
0 
(0
) 
21
 
(1
7)
 
35
 
(2
6)
 
18
 
(1
4)
 
3 
(1
00
) 
21
 
(7
2)
 
5 
(3
6)
 
1 
(1
00
) 
77
 
(7
2)
 
2 
(1
00
) 
0 
(0
) 
18
3 
(3
2)
<4
 
w
ar
ts
 
in
 
p
at
ie
n
t  
0 
(0
) 
0 
(0
) 
0 
(0
) 
31
 
(2
5)
 
60
 
(4
4)
 
40
 
(3
2)
 
3 
(1
00
) 
9 
(3
1)
 
12
 
(8
6)
 
1 
(1
00
) 
63
 
(5
9)
 
1 
(5
0)
 
2 
(1
00
) 
22
2 
(3
8)
Pa
rt
 
of
 
cl
u
st
er
2 
(2
0)
 
5 
(6
3)
 
7 
(5
4)
 
47
 
(3
8)
 
26
 
(1
9)
 
55
 
(4
4)
 
2 
(6
7)
 
11
 
(3
8)
 
0 
(0
) 
0 
(0
) 
20
 
(1
9)
 
0 
(0
) 
0 
(0
) 
17
5 
(3
0)
In
co
n
ve
n
ie
n
ce
a
7 
(7
0)
 
8 
(1
00
) 
11
 
(8
5)
 
10
1 
(8
1)
 
11
2 
(8
2)
 
91
 
(7
2)
 
3 
(1
00
) 
27
 
(9
3)
 
7 
(5
0)
 
1 
(1
00
) 
89
 
(8
3)
 
1 
(5
0)
 
2 
(1
00
) 
26
0 
(8
0)
D
at
a  
ar
e  
n
u
m
be
rs
 
(p
er
ce
n
ta
ge
s)
.
a
Pa
in
, i
rr
it
at
io
n
, o
r 
co
sm
et
ic
al
 
in
co
n
ve
n
ie
n
ce
.l Virology 55 (2012) 250– 255 253
5. Discussion
5.1. Main ﬁndings
In the present study, HPV 27, 57, 2 and 1 were the most prevalent
HPV types. In only 14% of warts other HPV types were detected. The
clinical proﬁle of warts associated with HPV 1 from the mu genus
differed from those associated with HPV 27, 57 and 2 from the alpha
genus. Warts with HPV 1 usually occurred in children, preferentially
on a plantar surface, and had a short duration before presentation
to the physician. In 74% of patients with multiple warts, one HPV
type was  shared in all warts of that patient.
5.2. Comparison with literature
Three other large HPV prevalence studies analysing cutaneous
wart-associated HPV types have been conducted, all in selected
dermatology populations.6,8,9 In these studies, different HPV type
prevalences were reported. For example, the prevalence of HPV
1 was reported to be 44% by Hagiwara et al., 27% by Iftner et al.,
and 4% by Rubben et al., compared to 19% in the present study.
These differences may  be due (in part) to regional differences, or
to patient selection. Our study was conducted in primary care, in
which patient selection is less likely to have occurred than, for
example, in a dermatology department. Alternatively, this discrep-
ancy may  be explained by the use of different HPV detection and
typing methods in each study.
The observation that HPV 1 is related to young patients, plantar
location, and short duration is in line with others.9,16 Furthermore,
in the prevalence studies, the higher the proportion of plantar
warts, the higher the reported prevalence of HPV 1.6,8,9 However,
Hagiwara et al., Chen et al., and Tomson et al. found no relation
with age.6,7,11 The reasons for this are not clear, but may be inﬂu-
enced by their study population with a very low prevalence of HPV
2/27/576,7 or HPV 1.11
In the current study, the presence of multiple HPV types was
detected in 16% of all swabs, which is more than reported in other
studies6,9,20,24,25; this is probably due to our HSL-PCR/MPG method
which is speciﬁcally capable of detecting multiple HPV types per
sample.20 These warts with multiple HPV types were analysed sep-
arately from the warts with a single HPV type, since combining
them would dilute associations with patient characteristics and
reduce the clarity of interpretation. In addition to the highly preva-
lent HPV 27, 57, 2 and 1 in warts with a single type, HPV 4 and
63 were also frequently detected in warts with multiple types.
We hypothesize that in a wart in which multiple HPV types are
detected, usually only one HPV type will be responsible for the
development of the wart. This is supported by evidence on the
clonal origin of warts,26 and by a recent study which found that
within a deﬁned cervical intraepithelial neoplastic lesion, only one
HPV type is present.27 In the latter study, analysis was done on dis-
sected lesional cells for which biopsies were needed. For the present
primary care population, however, non-invasive swabs of the lesion
were used and the sensitive HSL-PCR/MPG could have picked up a
passenger HPV type present on the skin.28,29 We  could not use the
relative abundance of HPV types, because the HSL-PCR/MPG tech-
nology is not a quantitative method. Results presented by de Koning
et al. support that HPV types identiﬁed in wart swabs are represen-
tative for the HPV type present in the wart biopsy by showing a
very high concordance (96%) between the HPV type detected in
the wart swabs and wart biopsies: comparing HPV types on dif-
ferent sites, 24/25 wart swabs, 19/25 perilesional swabs and 9/25
normal epithelium swabs were identical to the wart biopsy. In
the perilesional and normal epithelium swabs 3 and 2 multiple
infections were detected and 2/25 and 11/25 were HPV nega-
tive, respectively.19 Alternatively, a co-infection of single cells with
254 S.C. Bruggink et al. / Journal of Clinical Virology 55 (2012) 250– 255
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Number of warts in patient <4, mean 38% (CI 35-43)   
-40%
-30%
-20%
-10%
Mean
10%
20%
30%
40%
-40%
-30%
-20%
-10%
Mean
10%
20%
30%
40%
-40%
-30%
-20%
-10%
Mean
10%
20%
30%
40%
-40%
-30%
-20%
-10%
Mean
10%
20%
30%
40%
Fig. 1. Patient characteristics of warts in relation to the four most prevalent HPV types (n = 577). X-axis represents the mean proportion of speciﬁc patient characteristic in
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ultiple HPV types could be responsible for the development of
ome warts with multiple types24; for completeness, the results of
ensitivity analysis including the warts with multiple types were
omparable.
.3. Strengths and limitations
The present study population was a large non-selected sample
f patients with ﬁrst presentation of single or multiple warts in
rimary care. However, HPV type prevalence could be different in
he general population since HPV types causing warts with little
nconvenience are underrepresented in primary care. Only 7% of all
wabs were negative for HPV DNA. The HSL-PCR/MPG was  designed
o amplify all HPV types previously found in cutaneous warts as well
s related types from the same viral species.4 Viral loads below the
etection limit of the assay, other or unknown HPV types, or not
et described variants of the types included in the assay may  be
nvolved in these negative swabs. Also, lesions (e.g. callus) could
ave been misdiagnosed as warts or residual hyperkeratotic lesions
ollowing HPV clearance could have been sampled; however, no
istological investigation of the warts was made. Also, no data on
osaic warts were collected, since this was one of the exclusion
riteria.
.4. Implications
This is the ﬁrst large study combining a comprehensive genotyp-
ng assay analysing all known cutaneous wart-associated HPV types
nd simple non-invasive swabs to collect viral DNA. This could be
f special interest if speciﬁc HPV infections prove to be associated
ith clearance or response to speciﬁc treatments. In that case, HPV
enotyping or HPV type assessment based on clinical proﬁles may
ecome relevant for daily practice.portions do not overlap.
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